BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10200270)

  • 1. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
    Kelavkar UP; Badr KF
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
    Wang Q; Zambetti GP; Suttle DP
    Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
    Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R
    J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
    Kelavkar UP; Parwani AV; Shappell SB; Martin WD
    Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.
    Taylor AM; Hanchett R; Natarajan R; Hedrick CC; Forrest S; Nadler JL; McNamara CA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2069-74. PubMed ID: 16037566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
    Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
    Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ku autoantigen (DNA helicase) is required for interleukins-13/-4-induction of 15-lipoxygenase-1 gene expression in human epithelial cells.
    Kelavkar UP; Wang S; Badr KF
    Genes Immun; 2000; 1(4):237-50. PubMed ID: 11196700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
    Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
    Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages.
    Wen Y; Gu J; Chakrabarti SK; Aylor K; Marshall J; Takahashi Y; Yoshimoto T; Nadler JL
    Endocrinology; 2007 Mar; 148(3):1313-22. PubMed ID: 17170102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of c-Fos enhances the transcription of human arachidonate 12-lipoxygenase in A431 cells.
    Chen BK; Chang WC
    Biochem Biophys Res Commun; 1999 Aug; 261(3):848-52. PubMed ID: 10441514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
    Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
    Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
    Zhang D; Cao D; Russell R; Pizzorno G
    Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation.
    Liu C; Xu D; Sjöberg J; Forsell P; Björkholm M; Claesson HE
    Exp Cell Res; 2004 Jul; 297(1):61-7. PubMed ID: 15194425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of an enhancer sequence in the promoter region of human 15-lipoxygenase (15-LO) gene.
    Kelavkar U; Wang S; Montero A; Badr K
    Adv Exp Med Biol; 1999; 469():67-74. PubMed ID: 10667312
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase.
    Emerson MR; LeVine SM
    Brain Res; 2004 Sep; 1021(1):140-5. PubMed ID: 15328042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
    Pesch J; Brehm U; Staib C; Grummt F
    J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.